Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner Patricia B. Cerrito [email_address] ...
Objectives <ul><li>To examine some issues with traditional statistical models and their basic assumptions </li></ul><ul><l...
Surrogate Versus Real Endpoints <ul><li>Because clinical trials tend to be short term, they use high risk patients and sur...
One Versus Many Endpoints <ul><li>Clinical trials generally have one survival endpoint-time to recurrence, time to death, ...
Homogeneous Versus Heterogeneous Data <ul><li>Clinical trials generally use inclusion/exclusion criteria to define a homog...
Large Versus Small Samples <ul><li>Clinical trials tend to use the smallest sample possible to achieve the desired power <...
Rare Occurrences <ul><li>Clinical trials not large enough to find all potential rare occurrences </li></ul><ul><li>Health ...
Example 1 <ul><li>Ottenbacher, Kenneth J. Ottenbacher, Heather R. Tooth, Leigh. Ostir, Glenn V. </li></ul><ul><li>A review...
Example 1 <ul><li>Statistical significance testing or confidence intervals were reported in all articles. Methods for sele...
Example 1 <ul><li>Fewer than 50% of the articles indicated if interactions were tested or met the recommended events per i...
Example 2 <ul><li>Brown, James M. O'Brien, Sean M. Wu, Changfu. Sikora, Jo Ann H. Griffith, Bartley P. Gammie, James S. Ti...
Example 2 <ul><li>108,687 isolated aortic valve replacements were analyzed. Time-related trends were assessed by comparing...
Example 2 <ul><li>RESULTS:  There was a dramatic shift toward use of bioprosthetic valves.  </li></ul><ul><li>Aortic valve...
Example 2 <ul><li>Female sex, age older than 70 years, and ejection fraction less than 30% were all related to higher mort...
Central Limit Theorem <ul><li>As the sample size increases to infinity, the distribution of the sample average approaches ...
Central Limit Theorem <ul><li>In addition, the sample mean is very susceptible to the influence of outliers.  </li></ul><u...
Nonparametric Statistics <ul><li>Nonparametric models still require symmetry. </li></ul><ul><li>Many populations are highl...
Dataset <ul><li>We use data from the National Inpatient Sample from 2005 </li></ul><ul><li>A stratified sample from 1000 h...
Distribution of Patient Stays
Normal Estimate
Kernel Density Estimation <ul><li>Instead of assuming that the population follows a known distribution, we can estimate it...
Kernel Density Estimation
Proc KDE <ul><li>proc   kde  data=nis.diabetesless50los; </li></ul><ul><li>univar los/gridl= 0  gridu= 50  method=srot out...
Kernel Estimate of Length of Stay
Sampling from NIS <ul><li>Given that the National Inpatient Sample has 8 million records, we can consider it to be an infi...
Examine Central Limit Theorem <ul><li>PROC SURVEYSELECT DATA=nis.nis_205 OUT=work.samples METHOD=SRS N=5 rep=100 noprint; ...
Sample Size=5
Sample Size=30
Sample Size=100
Sample Size=1000
Confidence Limit The confidence limit excludes much of the actual population distribution
Confidence Limit With Larger n
Discussion <ul><li>An over-reliance on the Central Limit Theorem can give a very misleading picture of the population dist...
Discussion <ul><li>This is true for both logistic and linear regression where the assumption of normality is required. </l...
Problems With Regression <ul><li>Logistic regression is not designed to predict rare occurrences </li></ul><ul><li>With a ...
Regression Equation
Threshold Value <ul><li>For Logistic regression, a threshold value is defined, and regression values above the threshold a...
Simple Regression
Classification Table
Classification With 3 Variables continued...
Classification With 3 Variables
Models <ul><li>Linear regression: </li></ul><ul><ul><li>Y = β 0  + β 1  X 1  + β 2 X 2  …….+ β k  X k </li></ul></ul><ul><...
Poisson Distribution <ul><li>The parameter of the Poisson Distribution,  λ , will represent the average mortality rate, sa...
Parameters <ul><li>The three conditions include approximately 25% of total hospitalizations, leaving 75% not accounted for...
Predictive Modeling <ul><li>Takes a different approach </li></ul><ul><li>Uses equal group sizes </li></ul><ul><ul><li>100%...
50/50 Split in the Data Filter data to mortality outcome Filter data to non-mortality outcome Use PROC SURVEYSELECT to ext...
75/25 Split in the Data
90/10 Split in the Data
Validation <ul><li>The reduced sample is partitioned into training/validation/testing sets </li></ul><ul><li>Only need tra...
 
Sampling Node
Misclassification in Regression
ROC Curves
 
Rule Induction Results
Variable Selection
 
ROC Curves
Decile <ul><li>Data are sorted and divided into deciles </li></ul><ul><li>True positive patients with highest confidence c...
Lift <ul><li>Target density  =number of actually positive instances in that decile the total number of instances in the de...
Discussion <ul><li>Predictive modeling in Enterprise Miner has some capabilities that are possible, but extremely difficul...
Summary <ul><li>Clinical trials do differ from health outcomes research and the statistical techniques required must be ad...
Upcoming SlideShare
Loading in...5
×

Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner by Patricia B. Cerrito

1,403

Published on

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,403
On Slideshare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
16
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner by Patricia B. Cerrito

  1. 1. Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner Patricia B. Cerrito [email_address] University of Louisville
  2. 2. Objectives <ul><li>To examine some issues with traditional statistical models and their basic assumptions </li></ul><ul><li>To examine the Central Limit Theorem and its necessity in statistical models </li></ul><ul><li>To look at the differences and similarities between clinical trials and health outcomes research </li></ul>
  3. 3. Surrogate Versus Real Endpoints <ul><li>Because clinical trials tend to be short term, they use high risk patients and surrogate endpoints </li></ul><ul><li>Use of statins reduce cholesterol levels but do they increase longevity and disease free survival? </li></ul><ul><li>Health outcomes data can examine real endpoints from the general population </li></ul>
  4. 4. One Versus Many Endpoints <ul><li>Clinical trials generally have one survival endpoint-time to recurrence, time to death, time to disease progression </li></ul><ul><li>Health outcomes can examine multiple endpoints simultaneously using survival data mining </li></ul>
  5. 5. Homogeneous Versus Heterogeneous Data <ul><li>Clinical trials generally use inclusion/exclusion criteria to define a homogeneous sample </li></ul><ul><li>Health outcomes have to rely upon heterogeneous data </li></ul><ul><ul><li>Populations are more gamma distributions than normal and this must be taken into consideration </li></ul></ul>
  6. 6. Large Versus Small Samples <ul><li>Clinical trials tend to use the smallest sample possible to achieve the desired power </li></ul><ul><ul><li>Database designed for analysis and data are very clean </li></ul></ul><ul><li>Health outcomes have an abundance of data and variables </li></ul><ul><ul><li>Power not an issue </li></ul></ul><ul><ul><li>Data are very messy and require considerable preprocessing </li></ul></ul>
  7. 7. Rare Occurrences <ul><li>Clinical trials not large enough to find all potential rare occurrences </li></ul><ul><li>Health outcomes have enough data to find rare occurrences and to predict the probability of occurrence </li></ul><ul><ul><li>Requires modifications to standard linear models </li></ul></ul><ul><ul><li>Predictive modeling much better at actual prediction </li></ul></ul>
  8. 8. Example 1 <ul><li>Ottenbacher, Kenneth J. Ottenbacher, Heather R. Tooth, Leigh. Ostir, Glenn V. </li></ul><ul><li>A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions. Journal of Clinical Epidemiology. 57(11):1147-52, 2004 Nov. </li></ul>continued...
  9. 9. Example 1 <ul><li>Statistical significance testing or confidence intervals were reported in all articles. Methods for selecting independent variables were described in 82%, and specific procedures used to generate the models were discussed in 65%. </li></ul>continued...
  10. 10. Example 1 <ul><li>Fewer than 50% of the articles indicated if interactions were tested or met the recommended events per independent variable ratio of 10:1. </li></ul><ul><li>Fewer than 20% of the articles described conformity to a linear gradient, examined collinearity, reported information on validation procedures, goodness-of-fit, discrimination statistics, or provided complete information on variable coding. </li></ul>
  11. 11. Example 2 <ul><li>Brown, James M. O'Brien, Sean M. Wu, Changfu. Sikora, Jo Ann H. Griffith, Bartley P. Gammie, James S. Title: Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. Source: Journal of Thoracic & Cardiovascular Surgery. 137(1):82-90, 2009 Jan. </li></ul>continued...
  12. 12. Example 2 <ul><li>108,687 isolated aortic valve replacements were analyzed. Time-related trends were assessed by comparing distributions of risk factors, valve types, and outcomes in 1997 versus 2006. </li></ul><ul><li>Differences in case mix were summarized by comparing average predicted mortality risks with a logistic regression model. </li></ul><ul><li>Differences across subgroups and time were assessed. </li></ul>continued...
  13. 13. Example 2 <ul><li>RESULTS: There was a dramatic shift toward use of bioprosthetic valves. </li></ul><ul><li>Aortic valve replacement recipients in 2006 were older (mean age 65.9 vs 67.9 years, P < .001) with higher predicted operative mortality risk (2.75 vs 3.25, P < .001) </li></ul><ul><li>Observed mortality and permanent stroke rate fell (by 24% and 27%, respectively). </li></ul>continued...
  14. 14. Example 2 <ul><li>Female sex, age older than 70 years, and ejection fraction less than 30% were all related to higher mortality, higher stroke rate and longer postoperative stay. </li></ul><ul><li>There was a 39% reduction in mortality with preoperative renal failure. </li></ul>
  15. 15. Central Limit Theorem <ul><li>As the sample size increases to infinity, the distribution of the sample average approaches a normal distribution with mean μ and variance σ 2 /n. </li></ul><ul><li>As n approaches infinity, the variance approaches zero. </li></ul><ul><li>Therefore, the distribution of the sample average starts to look like a straight line at the point μ if n is too large. </li></ul>continued...
  16. 16. Central Limit Theorem <ul><li>In addition, the sample mean is very susceptible to the influence of outliers. </li></ul><ul><li>Moreover, the confidence limits are defined based upon the assumption of normality and symmetry. Therefore, the existence of many outliers will skew the confidence interval. </li></ul>
  17. 17. Nonparametric Statistics <ul><li>Nonparametric models still require symmetry. </li></ul><ul><li>Many populations are highly skewed so that these models also have problems </li></ul>
  18. 18. Dataset <ul><li>We use data from the National Inpatient Sample from 2005 </li></ul><ul><li>A stratified sample from 1000 hospitals from 37 states </li></ul><ul><li>Approximately 8 million inpatient stays </li></ul>
  19. 19. Distribution of Patient Stays
  20. 20. Normal Estimate
  21. 21. Kernel Density Estimation <ul><li>Instead of assuming that the population follows a known distribution, we can estimate it. </li></ul><ul><li>Kernel density estimation is an excellent method to use to do this </li></ul>continued...
  22. 22. Kernel Density Estimation
  23. 23. Proc KDE <ul><li>proc kde data=nis.diabetesless50los; </li></ul><ul><li>univar los/gridl= 0 gridu= 50 method=srot out=nis.kde50 bwm= 3 ; </li></ul><ul><li>run ; </li></ul>
  24. 24. Kernel Estimate of Length of Stay
  25. 25. Sampling from NIS <ul><li>Given that the National Inpatient Sample has 8 million records, we can consider it to be an infinite population. Therefore, we can sample from this population to see if it can be estimated by the Central Limit Theorem </li></ul><ul><li>We start with extracting 100 different samples of size N=5 </li></ul>
  26. 26. Examine Central Limit Theorem <ul><li>PROC SURVEYSELECT DATA=nis.nis_205 OUT=work.samples METHOD=SRS N=5 rep=100 noprint; </li></ul><ul><li>RUN; </li></ul><ul><li>proc means data=work.samples noprint; </li></ul><ul><li>by replicate; </li></ul><ul><li>var los; </li></ul><ul><li>output out=out mean=mean; </li></ul><ul><li>run; </li></ul>
  27. 27. Sample Size=5
  28. 28. Sample Size=30
  29. 29. Sample Size=100
  30. 30. Sample Size=1000
  31. 31. Confidence Limit The confidence limit excludes much of the actual population distribution
  32. 32. Confidence Limit With Larger n
  33. 33. Discussion <ul><li>An over-reliance on the Central Limit Theorem can give a very misleading picture of the population distribution. </li></ul><ul><li>Kernel density estimation (PROC KDE) allows an examination of the entire population distribution instead of just using the mean to represent the population. </li></ul><ul><li>Without the assumption of normality, we need to use predictive modeling. </li></ul>
  34. 34. Discussion <ul><li>This is true for both logistic and linear regression where the assumption of normality is required. </li></ul><ul><li>The two regression techniques do not work well with skewed populations. </li></ul><ul><li>We first look at logistic regression for rare occurrences </li></ul>
  35. 35. Problems With Regression <ul><li>Logistic regression is not designed to predict rare occurrences </li></ul><ul><li>With a rare occurrence, logistic regression will predict virtually all observations as non-occurrences </li></ul><ul><li>The accuracy will be high but the predictive ability of the model will be virtually nil. </li></ul>
  36. 36. Regression Equation
  37. 37. Threshold Value <ul><li>For Logistic regression, a threshold value is defined, and regression values above the threshold are predicted as 1 </li></ul><ul><li>Regression values below the threshold are predicted as 0 </li></ul><ul><li>Choice of threshold value optimizes error rate </li></ul>
  38. 38. Simple Regression
  39. 39. Classification Table
  40. 40. Classification With 3 Variables continued...
  41. 41. Classification With 3 Variables
  42. 42. Models <ul><li>Linear regression: </li></ul><ul><ul><li>Y = β 0 + β 1 X 1 + β 2 X 2 …….+ β k X k </li></ul></ul><ul><li>Logistic regression: </li></ul><ul><ul><li>log e (p/1− p) = β 0 + β 1 Χ 1 + β 2 Χ 2 …….β n Χ n </li></ul></ul><ul><li>Poisson regression </li></ul><ul><ul><li>log e (Y) = β 0 + β 1 Χ 1 + β 2 Χ 2 …….β n Χ n </li></ul></ul>
  43. 43. Poisson Distribution <ul><li>The parameter of the Poisson Distribution, λ , will represent the average mortality rate, say 2%. </li></ul><ul><li>Then the sample size times 2% will give the estimate for the number of deaths, say 1,000,000*0.02=20,000 </li></ul><ul><li>However, the problem still persists. </li></ul><ul><li>For example, septicemia has a 26% mortality rate, pneumonia has a 7.5% rate </li></ul>
  44. 44. Parameters <ul><li>The three conditions include approximately 25% of total hospitalizations, leaving 75% not accounted for. </li></ul><ul><li>The Poisson distribution can be accurate on those patients but cannot determine anything about the remaining 75% </li></ul><ul><li>If more patient conditions are added, the 25% will increase but not to the point that the model will have good predictability </li></ul>
  45. 45. Predictive Modeling <ul><li>Takes a different approach </li></ul><ul><li>Uses equal group sizes </li></ul><ul><ul><li>100% of the rarest level </li></ul></ul><ul><ul><li>Equal sample size of other level </li></ul></ul><ul><ul><li>Randomizes the selection of the sampling </li></ul></ul><ul><li>Uses prior probabilities to choose the optimal model </li></ul>
  46. 46. 50/50 Split in the Data Filter data to mortality outcome Filter data to non-mortality outcome Use PROC SURVEYSELECT to extract a subsample of non-mortality outcome Append the mortality outcome data to subsample
  47. 47. 75/25 Split in the Data
  48. 48. 90/10 Split in the Data
  49. 49. Validation <ul><li>The reduced sample is partitioned into training/validation/testing sets </li></ul><ul><li>Only need training/testing sets for regression models </li></ul><ul><li>Model is validated on the testing set </li></ul>
  50. 51. Sampling Node
  51. 52. Misclassification in Regression
  52. 53. ROC Curves
  53. 55. Rule Induction Results
  54. 56. Variable Selection
  55. 58. ROC Curves
  56. 59. Decile <ul><li>Data are sorted and divided into deciles </li></ul><ul><li>True positive patients with highest confidence come first </li></ul><ul><li>Next, positive patients with lower confidence. </li></ul><ul><li>True negative cases with lowest confidence come next </li></ul><ul><li>Next, negative cases with highest confidence. </li></ul>
  57. 60. Lift <ul><li>Target density =number of actually positive instances in that decile the total number of instances in the decile. </li></ul><ul><li>The lift =the ratio of the target density for the decile to the target density over all the test data. </li></ul><ul><li>Way to find patients most at risk for mortality (or infection) </li></ul>
  58. 61. Discussion <ul><li>Predictive modeling in Enterprise Miner has some capabilities that are possible, but extremely difficult in SAS/Stat </li></ul><ul><ul><li>Sampling a rare occurrence to a 50/50 split </li></ul></ul><ul><ul><li>Partitioning to validate the results </li></ul></ul><ul><ul><li>Comparing multiple models to find the one that is optimal </li></ul></ul><ul><ul><li>Variable selection </li></ul></ul>
  59. 62. Summary <ul><li>Clinical trials do differ from health outcomes research and the statistical techniques required must be adapted to outcomes research </li></ul><ul><li>Model assumptions are important, but too often ignored </li></ul><ul><li>We need to look at results in detail </li></ul><ul><li>Superficial consideration of results can lead to very erroneous conclusions </li></ul>
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×